"10.1371_journal.pone.0050640","plos one","2012-12-05T00:00:00Z","Shanker Swaminathan; Matthew J Huentelman; Jason J Corneveaux; Amanda J Myers; Kelley M Faber; Tatiana Foroud; Richard Mayeux; Li Shen; Sungeun Kim; Mari Turk; John Hardy; Eric M Reiman; Andrew J Saykin; the Alzheimer's Disease Neuroimaging Initiative (ADNI) and the NIA-LOAD/NCRAD Family Study Group","Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Neurogenomics Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona, United States of America; The Arizona Alzheimers Consortium, Phoenix, Arizona, United States of America; Departments of Psychiatry and Behavioral Sciences, and Human Genetics and Genomics, University of Miami, Miller School of Medicine, Miami, Florida, United States of America; Johnnie B. Byrd Sr. Alzheimers Center and Research Institute, Tampa, Florida, United States of America; Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; The Gertrude H. Sergievsky Center, The Taub Institute for Research on Alzheimers Disease and the Aging Brain, and the Department of Neurology, Columbia University College of Physicians and Surgeons, New York, New York, United States of America; Department of Molecular Neuroscience and Reta Lila Research Laboratories, University College London Institute of Neurology, London, United Kingdom; Banner Alzheimer’s Institute, Phoenix, Arizona, United States of America","Conceived and designed the experiments: SS MJH LS AS. Performed the experiments: SS MJH JJC AJM KMF TF RM LS MT JH EMR AS. Analyzed the data: SS MJH LS SK AS. Contributed reagents/materials/analysis tools: MJH JJC AJM KMF AS. Wrote the paper: SS MJH JJC AJM KMF TF RM LS SK MT JH EMR AS.","Genotyping of the TGen cohort was supported by Kronos Science. This study was partly funded by Glaxo Smith Kline. Data collection and sharing for the Alzheimers Disease Neuroimaging Initiative (ADNI) project was funded by the ADNI (NIH U01AG024904; RC2AG036535). ADNI is funded by the NIA, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffman-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","12","Shanker Swaminathan","SS",14,TRUE,4,12,5,13,TRUE,TRUE,FALSE,0,NA,FALSE
